دورية أكاديمية
Vascular events in patients with head and neck cancer: A systematic review and meta-analysis.
| العنوان: | Vascular events in patients with head and neck cancer: A systematic review and meta-analysis. |
|---|---|
| المؤلفون: | Monaghan NP; Department of Otolaryngology, Medical University of South Carolina, Charleston, South Carolina, USA.; College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Duckett KA; Department of Otolaryngology, Medical University of South Carolina, Charleston, South Carolina, USA.; College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Nguyen SA; Department of Otolaryngology, Medical University of South Carolina, Charleston, South Carolina, USA., Newman JG; Department of Otolaryngology, Medical University of South Carolina, Charleston, South Carolina, USA., Albergotti WG; Department of Otolaryngology, Medical University of South Carolina, Charleston, South Carolina, USA., Kejner AE; Department of Otolaryngology, Medical University of South Carolina, Charleston, South Carolina, USA. |
| المصدر: | Head & neck [Head Neck] 2024 Jul; Vol. 46 (7), pp. 1557-1572. Date of Electronic Publication: 2024 Feb 09. |
| نوع المنشور: | Systematic Review; Journal Article; Meta-Analysis |
| اللغة: | English |
| بيانات الدورية: | Publisher: John Wiley And Sons Country of Publication: United States NLM ID: 8902541 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0347 (Electronic) Linking ISSN: 10433074 NLM ISO Abbreviation: Head Neck Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: New York, NY : John Wiley And Sons Original Publication: New York, NY : J. Wiley, c1989- |
| مواضيع طبية MeSH: | Head and Neck Neoplasms*/therapy, Humans ; Incidence ; Vascular Diseases/etiology ; Stroke/etiology ; Stroke/epidemiology ; Stroke/prevention & control |
| مستخلص: | Objective: To assess the incidence of vascular events in patients with head and neck cancer. Review Methods: Primary studies identified through April 2023. Meta-analysis was performed. Results: There were 146 studies included in the systematic review. Rates of events were collected in the overall group, those with chemoprophylaxis, and those that underwent surgery, radiation, or chemotherapy. Of 1 184 160 patients, 4.3% had a vascular event. Radiation therapy had highest risk of overall events and stroke when compared to surgery and chemotherapy. Chemotherapy had a higher risk of stroke and overall events when compared to surgery. Conclusions: Vascular events occur in 4%-5% of patients with head and neck cancer. Our data does not support the use of routine anticoagulation. Patients undergoing radiation therapy had the highest frequency of events. (© 2024 Wiley Periodicals LLC.) |
| References: | Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7‐33. Rettig EM, D'Souza G. Epidemiology of head and neck cancer. Surg Oncol Clin N Am. 2015;24(3):379‐396. Rana JS, Khan SS, Lloyd‐Jones DM, Sidney S. Changes in mortality in top 10 causes of death from 2011 to 2018. J Gen Intern Med. 2021;36(8):2517‐2518. Florido R, Daya NR, Ndumele CE, et al. Cardiovascular disease risk among cancer survivors: the atherosclerosis risk in communities (ARIC) study. J Am Coll Cardiol. 2022;80(1):22‐32. Bauer KA. Risk and prevention of venous thromboembolism in adults with cancer. UpToDate. 2023;1:8‐12. Prandoni P. Cancer and thromboembolic disease: how important is the risk of thrombosis? Cancer Treat Rev. 2002;28(3):133‐136. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I4‐I8. Fernandes CJ, Morinaga LTK, Alves JLJ, et al. Cancer‐associated thrombosis: the when, how and why. Eur Respir Rev. 2019;28(151):180119. Kwon HK, Han KD, Cheon YI, et al. The incidence of myocardial infarction and stroke in head and neck cancer patients. Sci Rep. 2021;11(1):4174. Wilbers J, Sondag L, Mulder S, Siegerink B, van Dijk EJ. Cancer prevalence higher in stroke patients than in the general population: the Dutch String‐of‐Pearls Institute (PSI) Stroke study. Eur J Neurol. 2020;27(1):85‐91. Haen P, Mege D, Crescence L, Dignat‐George F, Dubois C, Panicot‐Dubois L. Thrombosis risk associated with head and neck cancer: a review. Int J Mol Sci. 2019;20(11):1‐24. Tham T, Rahman L, Persaud C, Olson C, Costantino P. Venous thromboembolism risk in head and neck cancer: significance of the preoperative platelet‐to‐lymphocyte ratio. Otolaryngol Head Neck Surg. 2018;159(1):85‐91. Cramer JD, Shuman AG, Brenner MJ. Antithrombotic therapy for venous thromboembolism and prevention of thrombosis in otolaryngology‐head and neck surgery: state of the art review. Otolaryngol Head Neck Surg. 2018;158(4):627‐636. Arthurs E, Hanna TP, Zaza K, Peng Y, Hall SF. Stroke after radiation therapy for head and neck cancer: what is the risk? Int J Radiat Oncol Biol Phys. 2016;96(3):589‐596. Dardiotis E, Aloizou AM, Markoula S, et al. Cancer‐associated stroke: pathophysiology, detection and management (Review). Int J Oncol. 2019;54(3):779‐796. Ling DC, Vargo JA, Gebhardt BJ, et al. Dose–response modeling the risk of carotid bleeding events after stereotactic body radiation therapy for previously irradiated head and neck cancer. J Radiosurg SBRT. 2019;6(2):83‐89. Lee CL, Chen WS, Wee Y, et al. Direct oral anticoagulants are associated with superior survival outcomes than warfarin in patients with head and neck cancers. Cancers (Basel). 2022;14(3):1‐14. Key NS, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2020;38(5):496‐520. Cevik J, Middleton R, Ramakrishnan A, Cabalag M. Rationalizing post‐operative prophylactic anticoagulation in reconstructive head and neck cancer patients: a review. ANZ J Surg. 2021;91(12):2610‐2616. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. Bero L, Chartres N, Diong J, et al. The risk of bias in observational studies of exposures (ROBINS‐E) tool: concerns arising from application to observational studies of exposures. Syst Rev. 2018;7(1):242. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629‐634. Sterne JA, Egger M. Funnel plots for detecting bias in meta‐analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54(10):1046‐1055. Abdel‐Razeq H, Mansour A, Abdulelah H, et al. Thromboembolic events in cancer patients on active treatment with cisplatin‐based chemotherapy: another look! Thromb J. 2018;16:2. Abt NB, Tarabanis C, Miller AL, Puram SV, Varvares MA. Preoperative anemia displays a dose‐dependent effect on complications in head and neck oncologic surgery. Head Neck. 2019;41(9):3033‐3040. Addison D, Seidelmann SB, Janjua SA, et al. Human papillomavirus status and the risk of cerebrovascular events following radiation therapy for head and neck cancer. J Am Heart Assoc. 2017;6(9):1‐9. Agnelli G, Gussoni G, Bianchini C, et al. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo‐controlled, double‐blind study. Lancet Oncol. 2009;10(10):943‐949. Ali NS, Nawaz A, Junaid M, Kazi M, Akhtar S. Venous thromboembolism‐incidence of deep venous thrombosis and pulmonary embolism in patients with head and neck cancer: a tertiary care experience in Pakistan. Int Arch Otorhinolaryngol. 2015;19(3):200‐204. Alvarenga M, Almeida A, Horta R. Incidence and outcomes of thromboembolic events in plastic surgery infirmary patients. Cir Cir. 2022;90(5):617‐622. Alwani MM, Jones AJ, Novinger LJ, et al. Impact of sarcopenia on outcomes of autologous head and neck free tissue reconstruction. J Reconstr Microsurg. 2020;36(5):369‐378. Ambani SW, Bengur FB, Varelas LJ, et al. Standard fixed enoxaparin dosing for venous thromboembolism prophylaxis leads to low peak anti‐factor Xa levels in both head and neck and breast free flap patients. J Reconstr Microsurg. 2022;38(9):749‐756. Bachaud JM, David JM, Shubinski RE, et al. Predictive factors of a complete response to and adverse effects of a CDDP‐5FU combination as primary therapy for head and neck squamous carcinomas. J Laryngol Otol. 1993;107(10):924‐930. Bachaud JM, Delannes M, Allouache N, et al. Radiotherapy of stage I and II carcinomas of the mobile tongue and/or floor of the mouth. Radiother Oncol. 1994;31(3):199‐206. Balm AJ, Rasch CR, Schornagel JH, et al. High‐dose superselective intra‐arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck. 2004;26(6):485‐493. Bhattacharyya N, Fried MP. Benchmarks for mortality, morbidity, and length of stay for head and neck surgical procedures. Arch Otolaryngol Head Neck Surg. 2001;127(2):127‐132. Bhide SA, Ahmed M, Barbachano Y, Newbold K, Harrington KJ, Nutting CM. Sequential induction chemotherapy followed by radical chemo‐radiation in the treatment of locoregionally advanced head‐and‐neck cancer. Br J Cancer. 2008;99(1):57‐62. Bigelow EO, Blackford AL, Eytan DF, Eisele DW, Fakhry C. Burden of comorbidities is higher among elderly survivors of oropharyngeal cancer compared with controls. Cancer. 2020;126(8):1793‐1803. Bourhis J, Rivera F, Mesia R, et al. Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol. 2006;24(18):2866‐2872. Bright CJ, Hawkins MM, Guha J, et al. Risk of cerebrovascular events in 178 962 five‐year survivors of cancer diagnosed at 15 to 39 years of age: the TYACSS (Teenage and Young Adult Cancer Survivor Study). Circulation. 2017;135(13):1194‐1210. Brown DH, Mulholland S, Yoo JH, et al. Internal jugular vein thrombosis following modified neck dissection: implications for head and neck flap reconstruction. Head Neck. 1998;20(2):169‐174. Buglione M, Maddalo M, Mazzeo E, et al. Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors. Tumori. 2015;101(5):585‐592. Buitelaar DR, Balm AJ, Antonini N, van Tinteren H, Huitink JM. Cardiovascular and respiratory complications after major head and neck surgery. Head Neck. 2006;28(7):595‐602. Bur AM, Brant JA, Mulvey CL, et al. Association of clinical risk factors and postoperative complications with unplanned hospital readmission after head and neck cancer surgery. JAMA Otolaryngol Head Neck Surg. 2016;142(12):1184‐1190. Carpenter DJ, Mowery YM, Broadwater G, et al. The risk of carotid stenosis in head and neck cancer patients after radiation therapy. Oral Oncol. 2018;80:9‐15. Chang CF, Kuo YL, Pu C, Chou YJ. Neck dissection and stroke in patients with oral cavity cancer: a population‐based cohort study. Head Neck. 2017;39(1):63‐70. Chen CM, Disa JJ, Cordeiro PG, Pusic AL, McCarthy CM, Mehrara BJ. The incidence of venous thromboembolism after oncologic head and neck reconstruction. Ann Plast Surg. 2008;60(5):476‐479. Chen MC, Kuan FC, Huang SF, et al. Accelerated risk of premature ischemic stroke in 5‐year survivors of nasopharyngeal carcinoma. Oncologist. 2019;24(9):e891‐e897. Chera BS, Sheth SH, Patel SA, et al. Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate‐risk and high‐risk head and neck squamous cell carcinoma. Cancer. 2021;127(23):4447‐4454. Chiang S, Cohen B, Blackwell K. Myocardial infarction after microvascular head and neck reconstruction. Laryngoscope. 2002;112(10):1849‐1852. Cho H, Choi JH, Kang SY, et al. Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin. Korean J Intern Med. 2022;37(3):653‐659. Choong NW, Kozloff M, Taber D, et al. Phase II study of sunitinib malate in head and neck squamous cell carcinoma. Invest New Drugs. 2010;28(5):677‐683. Chu CN, Chen PC, Bai LY, Muo CH, Sung FC, Chen SW. Young nasopharyngeal cancer patients with radiotherapy and chemotherapy are most prone to ischaemic risk of stroke: a national database, controlled cohort study. Clin Otolaryngol. 2013;38(1):39‐47. Chu CN, Chen SW, Bai LY, Mou CH, Hsu CY, Sung FC. Increase in stroke risk in patients with head and neck cancer: a retrospective cohort study. Br J Cancer. 2011;105(9):1419‐1423. Clayburgh DR, Stott W, Cordiero T, et al. Prospective study of venous thromboembolism in patients with head and neck cancer after surgery. JAMA Otolaryngol Head Neck Surg. 2013;139(11):1143‐1150. Cooney MM, Tserng KY, Makar V, et al. A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neck. Cancer Chemother Pharmacol. 2005;55(3):295‐300. Cramer JD, Dilger AE, Schneider A, Smith SS, Samant S, Patel UA. Risk of venous thromboembolism among otolaryngology patients vs general surgery and plastic surgery patients. JAMA Otolaryngol Head Neck Surg. 2018;144(1):9‐17. Cramer JD, Patel UA, Maas MB, Samant S, Smith SS. Is neck dissection associated with an increased risk of postoperative stroke? Otolaryngol Head Neck Surg. 2017;157(2):226‐232. Datema FR, Poldermans D, Baatenburg de Jong RJ. Incidence and prediction of major cardiovascular complications in head and neck surgery. Head Neck. 2010;32(11):1485‐1493. Denaro N, Garrone O, Ghidini M, et al. Thrombotic events during lenvatinib treatment: a single institution experience. J Clin Med. 2022;11(24):1‐11. Dorresteijn LD, Kappelle AC, Boogerd W, et al. Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol. 2002;20(1):282‐288. Flavill E, Fang YV, Miles B, Truelson J, Perkins S. Induction chemotherapy followed by concurrent chemoradiotherapy for advanced stage oropharyngeal squamous cell carcinoma with HPV and P16 testing. Ann Otol Rhinol Laryngol. 2014;123(5):365‐373. Fukuda S, Sakai N, Kamata SE, et al. Surgical results of skull base surgery for the treatment of head and neck malignancies involving skull base: multi‐institutional studies on 143 cases in Japan. Auris Nasus Larynx. 2001;28(Suppl):S71‐S75. Garden AS, Lippman SM, Morrison WH, et al. Does induction chemotherapy have a role in the management of nasopharyngeal carcinoma? Results of treatment in the era of computerized tomography. Int J Radiat Oncol Biol Phys. 1996;36(5):1005‐1012. Garritano FG, Lehman EB, Andrews GA. Incidence of venous thromboembolism in otolaryngology‐head and neck surgery. JAMA Otolaryngol Head Neck Surg. 2013;139(1):21‐27. Gavriel H, Thompson E, Kleid S, Chan S, Sizeland A. Safety of thromboprophylaxis after oncologic head and neck surgery. Study of 1018 patients. Head Neck. 2013;35(10):1410‐1414. Gibson MK, Li Y, Murphy B, et al. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2005;23(15):3562‐3567. Goshtasbi K, Birkenbeuel JL, Abouzari M, et al. Short‐term morbidity and predictors of adverse events following esthesioneuroblastoma surgery. Am J Rhinol Allergy. 2021;35(4):500‐506. Grecula JC, Smith RE, Rhoades CA, et al. Induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of head and neck. Cancer. 2000;89(12):2587‐2596. Haapio E, Kiviniemi T, Irjala H, Koivunen P, Airaksinen JKE, Kinnunen I. Incidence and predictors of 30‐day cardiovascular complications in patients undergoing head and neck cancer surgery. Eur Arch Otorhinolaryngol. 2016;273(12):4601‐4606. He XY, Hu CS, Ying HM, Wu YR, Zhu GP, Liu TF. Paclitaxel with cisplatin in concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol. 2010;267(5):773‐778. Hennessey P, Semenov YR, Gourin CG. The effect of deep venous thrombosis on short‐term outcomes and cost of care after head and neck cancer surgery. Laryngoscope. 2012;122(10):2199‐2204. Hitt R, Paz‐Ares L, Brandáriz A, et al. Induction chemotherapy with paclitaxel, cisplatin and 5‐fluorouracil for squamous cell carcinoma of the head and neck: long‐term results of a phase II trial. Ann Oncol. 2002;13(10):1665‐1673. Homma A, Sakashita T, Yoshida D, et al. Superselective intra‐arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer. Br J Cancer. 2013;109(12):2980‐2986. Hong JC, Kruser TJ, Gondi V, et al. Risk of cerebrovascular events in elderly patients after radiation therapy versus surgery for early‐stage glottic cancer. Int J Radiat Oncol Biol Phys. 2013;87(2):290‐296. Hsu CW, Huang YB, Kuo CC, Chen CY. Evaluating the primary prevention of ischemic stroke of oral antithrombotic therapy in head and neck cancer patients with radiation therapy. Biomed Res Int. 2016;2016:6205158. Huang G, Lu H, Li M, Lv Q, Chen Q. Association of total cholesterol and atherosclerotic cardiovascular disease in patients with follicular thyroid cancer: a real‐world study from Chinese populations. Medicine (Baltimore). 2021;100(39):e27310. Jacobs JR, Pajak TF, Al‐Sarraf M, et al. Chemotherapy following surgery for head and neck cancer. A radiation therapy oncology group study. Am J Clin Oncol. 1989;12(3):185‐189. Jelinek MJ, Foster NR, Zoroufy AJ, et al. A phase I trial adding poly(ADP‐ribose) polymerase inhibitor veliparib to induction carboplatin‐paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101. Oral Oncol. 2021;114:105171. Joyce LD, McQuarrie DG. Application of contemporary reconstructive techniques in head and neck surgery for anterior oral‐facial cancers. Surgery. 1976;80(3):373‐378. Kakei Y, Akashi M, Hasegawa T, Minamikawa T, Usami S, Komori T. Incidence of venous thromboembolism after oral oncologic surgery with simultaneous reconstruction. J Oral Maxillofac Surg. 2016;74(1):212‐217. Kang EJ, Lee YG, Koo M, et al. The risk of cardiovascular disease and stroke in survivors of head and neck cancer in Korea. Health Sci Rep. 2022;5(2):e517. Kharofa J, Choong N, Wang D, et al. Continuous‐course reirradiation with concurrent carboplatin and paclitaxel for locally recurrent, nonmetastatic squamous cell carcinoma of the head‐and‐neck. Int J Radiat Oncol Biol Phys. 2012;83(2):690‐695. Kim KJ, Song JE, Kim JY, et al. Effects of radioactive iodine treatment on cardiovascular disease in thyroid cancer patients: a nationwide cohort study. Ann Transl Med. 2020;8(19):1235. Kitano D, Yonezawa K, Iwae S, Sakakibara S. Internal jugular vein thrombosis and pulmonary thromboembolism after head and neck reconstructive surgery. J Plast Reconstr Aesthet Surg. 2021;74(6):1239‐1245. Kua VF, Ismail F, Chee Ee Phua V, Aslan NM. Carboplatin/5‐fluorouracil as an alternative to cisplatin/5‐fluorouracil for metastatic and recurrent head and neck squamous cell carcinoma and nasopharyngeal carcinoma. Asian Pac J Cancer Prev. 2013;14(2):1121‐1126. Kuan FC, Lee KD, Huang SF, et al. Radiotherapy is associated with an accelerated risk of ischemic stroke in oral cavity cancer survivors after primary surgery. Cancers (Basel). 2020;12(3):1‐10. Kulkarni AP, Chaukar DA, Patil VP, Metgudmath RB, Hawaldar RW, Divatia JV. Does tranexamic acid reduce blood loss during head and neck cancer surgery? Indian J Anaesth. 2016;60(1):19‐24. Kuo CY, Chen YT, Sun CK, Hung KC. Ischemic stroke following neck dissection in the elderly. Ci Ji Yi Xue Za Zhi. 2019;31(3):177‐181. Lee CC, Su YC, Ho HC, et al. Increased risk of ischemic stroke in young nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys. 2011;81(5):e833‐e838. Leong SS, Wee J, Tay MH, et al. Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: a phase II trial using a triplet combination. Cancer. 2005;103(3):569‐575. Liang J, Yu T, Wang X, et al. Free tissue flaps in head and neck reconstruction: clinical application and analysis of 93 patients of a single institution. Braz J Otorhinolaryngol. 2018;84(4):416‐425. Liang X, Chen X, Wang G, et al. Intraoperative hypotension, oliguria and operation time are associated with pulmonary embolism after radical resection of head and neck cancers: a case control study. BMC Anesthesiol. 2021;21(1):304. Ligh CA, Nelson JA, Wink JD, et al. An analysis of early oncologic head and neck free flap reoperations from the 2005–2012 ACS‐NSQIP dataset. J Plast Surg Hand Surg. 2016;50(2):85‐92. Li J, He Z, Tao Y, et al. Efficacy and safety of pembrolizumab monotherapy for recurrent/unresectable/metastatic oral squamous cell carcinoma: a single‐center study in China. J Oncol. 2022;2022:7283946. Li P, Sun L, Sun L. Influence of body mass index on survival and prognosis in squamous cell carcinoma of head and neck. Cancer Manag Res. 2020;12:3203‐3210. Lim WT, Ng QS, Ivy P, et al. A phase II study of pazopanib in Asian patients with recurrent/metastatic nasopharyngeal carcinoma. Clin Cancer Res. 2011;17(16):5481‐5489. Lin CY, Lin CL, Lo YC, Kao CH. Association between radioiodine treatment for thyroid cancer and risk of stroke. Head Neck. 2017;39(11):2311‐2318. Lin HW, Bhattacharyya N. Contemporary assessment of medical morbidity and mortality in head and neck surgery. Otolaryngol Head Neck Surg. 2012;146(3):385‐389. Liu CH, Chang JT, Lee TH, et al. Hypothyroidism and risks of cerebrovascular complications among patients with head and neck cancer after radiotherapy. BMC Neurol. 2021;21(1):30. Lodders JN, Parmar S, Stienen NL, et al. Incidence of symptomatic venous thromboembolism in oncological oral and maxillofacial operations: retrospective analysis. Br J Oral Maxillofac Surg. 2015;53(3):244‐250. Lopez M, el‐Bayar H, Hye RJ, Freischlag J. Carotid artery disease in patients with head and neck carcinoma. Am Surg. 1990;56(12):778‐781. Luthringer MM, Kim KG, Mukherjee TJ, Van Kouwenberg EA, Agag RL, Sinkin JC. Standardized perioperative protocol and routine ketorolac use for head and neck free flap reconstruction. Plast Reconstr Surg Glob Open. 2022;10(5):e4318. Machtay M, Rosenthal DI, Chalian AA, et al. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head‐and‐neck cancer. Int J Radiat Oncol Biol Phys. 2004;59(1):72‐77. MacNeil SD, Liu K, Garg AX, et al. A population‐based study of 30‐day incidence of ischemic stroke following surgical neck dissection. Medicine (Baltimore). 2015;94(33):e1106. Makita C, Okada S, Kajiura Y, et al. Vascular events from carotid artery atherosclerosis after radiation therapy for laryngeal and hypopharyngeal cancer: the incidence and risk factors. Nagoya J Med Sci. 2020;82(4):747‐761. Marcus K, Sullivan CB, Al‐Qurayshi Z, Buchakjian MR. Can red blood cell distribution width predict laryngectomy complications or survival outcomes? Ann Otol Rhinol Laryngol. 2022;131(10):1102‐1108. Miyamoto S, Sakuraba M, Nagamatsu S, Hayashi R. Salvage total pharyngolaryngectomy and free jejunum transfer. Laryngoscope. 2011;121(5):947‐951. Mourad M, Saman M, Stroman D, Lee T, Ducic Y. Carotid artery sacrifice and reconstruction in the setting of advanced head and neck cancer. Otolaryngol Head Neck Surg. 2015;153(2):225‐230. Mowery A, Light T, Clayburgh D. Venous thromboembolism incidence in head and neck surgery patients: analysis of the veterans affairs surgical quality improvement program (VASQIP) database. Oral Oncol. 2018;77:22‐28. Mukherjee A, Wiener HW, Griffin RL, et al. Traditional risk factors and cancer‐related factors associated with cardiovascular disease risk in head and neck cancer patients. Front Cardiovasc Med. 2022;9:1024846. Mulvey CL, Pronovost PJ, Gourin CG. Hospital volume and failure to rescue after head and neck cancer surgery. Otolaryngol Head Neck Surg. 2015;152(5):783‐789. Nagele P, Rao LK, Penta M, et al. Postoperative myocardial injury after major head and neck cancer surgery. Head Neck. 2011;33(8):1085‐1091. Nakamura H, Yano T, Fujii S, et al. Natural history of superficial head and neck squamous cell carcinoma under scheduled follow‐up endoscopic observation with narrow band imaging: retrospective cohort study. BMC Cancer. 2016;16(1):743. Nouraei SA, Al‐Yaghchi C, Sandhu GS, Giussani DA, Doyle P, Clarke PM. Incidence and significance of myocardial injury after surgical treatment of head and neck cancer. Laryngoscope. 2007;117(9):1581‐1587. Numajiri T, Sowa Y, Nishino K, et al. Use of systemic low‐dose unfractionated heparin in microvascular head and neck reconstruction: influence in free‐flap outcomes. J Plast Surg Hand Surg. 2016;50(3):135‐141. Okoye CC, Bucher J, Tatsuoka C, et al. Cardiovascular risk and prevention in patients with head and neck cancer treated with radiotherapy. Head Neck. 2017;39(3):527‐532. Ong HS, Gokavarapu S, Al‐Qamachi L, et al. Justification of routine venous thromboembolism prophylaxis in head and neck cancer reconstructive surgery. Head Neck. 2017;39(12):2450‐2458. Papadimitrakopoulou VA, Ginsberg LE, Garden AS, et al. Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ‐preservation approach in patients with paranasal sinus carcinoma. Cancer. 2003;98(10):2214‐2223. Parhar HS, Durham JS, Anderson DW, Rush B, Prisman E. The association between the nutrition‐related index and morbidity following head and neck microsurgery. Laryngoscope. 2020;130(2):375‐380. Patel R, Stokes WA, Roberts C, et al. Preoperative low‐molecular weight heparin chemoprophylaxis in head and neck free flap reconstruction. Am J Otolaryngol. 2023;44(2):103722. Patel RS, Makitie AA, Goldstein DP, et al. Morbidity and functional outcomes following gastro‐omental free flap reconstruction of circumferential pharyngeal defects. Head Neck. 2009;31(5):655‐663. Patil VM, Noronha V, Joshi A, et al. A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer. Cancer. 2019;125(18):3184‐3197. Pfister DG, Bajorin D, Motzer R, et al. Cisplatin, fluorouracil, and leucovorin. Increased toxicity without improved response in squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg. 1994;120(1):89‐95. Pfister DG, Su YB, Kraus DH, et al. Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined‐modality paradigm. J Clin Oncol. 2006;24(7):1072‐1078. Prasad KG, Nelson BG, Deig CR, Schneider AL, Moore MG. ACS NSQIP risk calculator: an accurate predictor of complications in major head and neck surgery? Otolaryngol Head Neck Surg. 2016;155(5):740‐742. Puram SV, Yarlagadda BB, Sethi R, et al. Transfusion in head and neck free flap patients: practice patterns and a comparative analysis by flap type. Otolaryngol Head Neck Surg. 2015;152(3):449‐457. Quraishi HA, Wax MK, Granke K, Rodman SM. Internal jugular vein thrombosis after functional and selective neck dissection. Arch Otolaryngol Head Neck Surg. 1997;123(9):969‐973. Reinke CE, Hadler RA, Karakousis GC, Fraker DL, Kelz RR. Does the presence of thyroid cancer increase the risk of venous thromboembolism in patients undergoing thyroidectomy? Surgery. 2011;150(6):1275‐1285. Rothman S, Zabarqa S, Pitaro J, Gavriel H, Marom T, Muallem KL. Head and neck cancer surgery in elderly patients: the role of frailty assessment. Eur Arch Otorhinolaryngol. 2023;280(3):1447‐1453. Saadoun R, Bengur FB, Moroni EA, et al. Assessment of BMI and venous thromboembolism rates in patients on standard chemoprophylaxis regimens after undergoing free tissue transfer to the head and neck. JAMA Otolaryngol Head Neck Surg. 2022;148(11):1051‐1058. Saito Y, Ando M, Omura G, et al. Induction chemotherapy for p16 positive oropharyngeal squamous cell carcinoma. Laryngoscope Investig Otolaryngol. 2016;1(2):28‐32. Schneider AL, Deig CR, Prasad KG, et al. Ability of the national surgical quality improvement program risk calculator to predict complications following total laryngectomy. JAMA Otolaryngol Head Neck Surg. 2016;142(10):972‐979. Schoenfeld JD, Hanna GJ, Jo VY, et al. Neoadjuvant nivolumab or nivolumab plus ipilimumab in untreated oral cavity squamous cell carcinoma: a phase 2 open‐label randomized clinical trial. JAMA Oncol. 2020;6(10):1563‐1570. Schwaab G, Kolb F, Julieron M, et al. Subtotal laryngectomy with cricohyoidopexy as first treatment procedure for supraglottic carcinoma: Institut Gustave‐Roussy experience (146 cases, 1974–1997). Eur Arch Otorhinolaryngol. 2001;258(5):246‐249. Seiwert TY, Haraf DJ, Cohen EE, et al. Phase I study of bevacizumab added to fluorouracil‐ and hydroxyurea‐based concomitant chemoradiotherapy for poor‐prognosis head and neck cancer. J Clin Oncol. 2008;26(10):1732‐1741. Semsar‐Kazerooni K, Richardson K, Forest VI, et al. Development and validation of the modified index of fragility in head and neck cancer surgery. J Otolaryngol Head Neck Surg. 2023;52(1):5. Sharma N, George NA, Sebastian P. Neurovascular complications after neck dissection: a prospective analysis at a tertiary care centre in south India. Indian J Surg Oncol. 2020;11(4):746‐751. Sherman EJ, Harris J, Bible KC, et al. Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double‐blind, placebo‐controlled, multicentre, phase 2 trial. Lancet Oncol. 2023;24(2):175‐186. Sinha S, Puram SV, Sethi RK, et al. Perioperative deep vein thrombosis risk stratification. Otolaryngol Head Neck Surg. 2017;156(1):118‐121. Smith GL, Smith BD, Buchholz TA, et al. Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy. J Clin Oncol. 2008;26(31):5119‐5125. Sou WK, Perng CK, Ma H, Shih YC. Perioperative myocardial infarction in free flap for head and neck reconstruction. Ann Plast Surg. 2022;88(Suppl 1):S56‐S61. Specenier PM, Van Den Brande J, Schrijvers D, et al. Docetaxel, ifosfamide and cisplatin (DIP) in squamous cell carcinoma of the head and neck. Anticancer Res. 2009;29(12):5137‐5142. Stack BC Jr, Spencer HJ, Lee CE, Medvedev S, Hohmann SF, Bodenner DL. Characteristics of inpatient thyroid surgery at US academic and affiliated medical centers. Otolaryngol Head Neck Surg. 2012;146(2):210‐219. Suh B, Shin DW, Park Y, et al. Increased cardiovascular risk in thyroid cancer patients taking levothyroxine: a nationwide cohort study in Korea. Eur J Endocrinol. 2019;180(1):11‐20. Suzuki S, Yasunaga H, Matsui H, Fushimi K, Saito Y, Yamasoba T. Cerebral infarction after intraarterial and intravenous chemoradiotherapy for head and neck cancer: a retrospective analysis using a Japanese inpatient database. Head Neck. 2016;38(9):1354‐1358. Szabó G, Kovács A. Intra‐arterial chemotherapy of head and neck tumours. Acta Chir Acad Sci Hung. 1979;20(1):49‐55. Tan TH, Zheng H, Cheo T, Tey J, Soon YY. Risk of stroke in nasopharyngeal cancer survivors: a National Registry‐Based Population Cohort Study. Neurology. 2022;98(2):e115‐e124. Thai L, McCarn K, Stott W, et al. Venous thromboembolism in patients with head and neck cancer after surgery. Head Neck. 2013;35(1):4‐9. Tham T, Costantino P. Comparison of venous thromboembolism risk stratification models in a high risk otolaryngology patient cohort. J Perioper Pract. 2019;29(5):129‐134. Thompson SK, Southern DA, McKinnon JG, Dort JC, Ghali WA. Incidence of perioperative stroke after neck dissection for head and neck cancer: a regional outcome analysis. Ann Surg. 2004;239(3):428‐431. Tipirneni KE, Bauter L, Arnold MA, Audlin JA, Ryan J, Marzouk M. Association of prolonged‐duration chemoprophylaxis with venous thromboembolism in high‐risk patients with head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2021;147(4):320‐328. Toulis KA, Viola D, Gkoutos G, Keerthy D, Boelaert K, Nirantharakumar K. Risk of incident circulatory disease in patients treated for differentiated thyroid carcinoma with no history of cardiovascular disease. Clin Endocrinol (Oxf). 2019;91(2):323‐330. Tsai MC, Hsieh CT, Hsu HY, et al. Association between thyroid cancer and cardiovascular disease risk: a nationwide observation study. Sci Rep. 2022;12(1):18438. Tzelnick S, Mizrachi A, Shavit SS, et al. Major head and neck surgeries in the elderly population, a match‐control study. Eur J Surg Oncol. 2021;47(8):1947‐1952. van der Boom T, Klein Hesselink EN, Kooistra HAM, et al. Risk factors for venous thromboembolism in patients treated for differentiated thyroid carcinoma. Endocr Relat Cancer. 2017;24(6):267‐273. Vedasoundaram P, Raghava Ks A, Periasamy K, et al. The effect of high dose rate interstitial implant on early and locally advanced oral cavity cancers: update and long‐term follow‐up study. Cureus. 2020;12(5):e7910. Vermorken JB, Mesia R, Rivera F, et al. Platinum‐based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med. 2008;359(11):1116‐1127. Walker AJ, Card TR, West J, Crooks C, Grainge MJ. Incidence of venous thromboembolism in patients with cancer—a cohort study using linked United Kingdom databases. Eur J Cancer. 2013;49(6):1404‐1413. Wilbers J, Dorresteijn LD, Haast R, et al. Progression of carotid intima media thickness after radiotherapy: a long‐term prospective cohort study. Radiother Oncol. 2014;113(3):359‐363. Wilbers J, Hoebers FJ, Boogerd W, et al. Prospective cohort study of carotid intima‐media thickness after irradiation. J Stroke Cerebrovasc Dis. 2014;23(10):2701‐2707. Wu YT, Chen CY, Lai WT, Kuo CC, Huang YB. Increasing risks of ischemic stroke in oral cancer patients treated with radiotherapy or chemotherapy: a nationwide cohort study. Int J Neurosci. 2015;125(11):808‐816. Xia WX, Lv X, Liang H, et al. A randomized controlled trial comparing two different schedules for cisplatin treatment in patients with locoregionally advanced nasopharyngeal cancer. Clin Cancer Res. 2021;27(15):4186‐4194. Yang Y, Wang T. Radiotherapy of the neck and carotid stenosis. J Biol Regul Homeost Agents. 2016;30(3):795‐799. Yeh CF, Chin YC, Hung W, Huang PI, Lan MY. Vertebral artery stenosis predicts cerebrovascular diseases following radiotherapy for nasopharyngeal carcinoma. Support Care Cancer. 2022;30(7):5821‐5830. Yeh TL, Hsieh CT, Hsu HY, et al. The risk of ischemic stroke in head and neck cancer patients and those who were treated with radiotherapy: a population‐based cohort study. Cancer Epidemiol Biomarkers Prev. 2022;31(5):1111‐1118. Yung KC, Piccirillo JF. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer. Arch Otolaryngol Head Neck Surg. 2008;134(10):1045‐1049. Zeng S, Chang CH, Sun M, Chen WM, Wu SY, Zhang J. Comparison of surgical complications after curative surgery in patients with oral cavity squamous cell carcinoma and sarcopenia. J Cachexia Sarcopenia Muscle. 2023;14(1):576‐584. Moubayed SP, Eskander A, Mourad MW, Most SP. Systematic review and meta‐analysis of venous thromboembolism in otolaryngology‐head and neck surgery. Head Neck. 2017;39(6):1249‐1258. Manzoor T, Ahmed Z, Sheikh NA, Khan MM. Pulmonary complications associated with head and neck cancer surgery. J Coll Physicians Surg Pak. 2007;17(9):558‐561. Sun L, Brody R, Candelieri D, et al. Risk of cardiovascular events among patients with head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2023;149(8):717‐725. Yu B, Akushevich I, Yashkin AP, Kravchenko J. Epidemiology of geographic disparities of myocardial infarction among older adults in the United States: analysis of 2000–2017 Medicare data. Front Cardiovasc Med. 2021;8:707102. Zhao LB, Shi HB, Park S, et al. Acute bleeding in the head and neck: angiographic findings and endovascular management. AJNR Am J Neuroradiol. 2014;35(2):360‐366. Vilas Boas PP, de Castro‐Afonso LH, Monsignore LM, Nakiri GS, de Mello‐Filho FV, Abud DG. Endovascular management of patients with head and neck cancers presenting with acute hemorrhage: a single‐center retrospective study. Cardiovasc Intervent Radiol. 2017;40(4):510‐519. |
| فهرسة مساهمة: | Keywords: head and neck cancer; hemorrhage; infarction; ischemia; thrombosis; vascular events |
| تواريخ الأحداث: | Date Created: 20240209 Date Completed: 20240605 Latest Revision: 20240607 |
| رمز التحديث: | 20240607 |
| DOI: | 10.1002/hed.27675 |
| PMID: | 38334324 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!